Remove Compliance Remove Fraud Remove Informed Consent Remove Presentation
article thumbnail

Introduction to Telebehavioral Health

AIHC

Compliance Considerations for Best Outcomes Written in collaboration with the AIHC Volunteer Education Committee Delivering mental health services via telehealth has increased since the COVID-19 pandemic. Obtaining informed consent with your patient is typically done before the first appointment.

article thumbnail

Embracing Technology: FDA Releases Draft Guidance on Decentralized Clinical Trials

Hall Render

The guidance describes DCT-specific considerations that may not be present in site-based clinical trials, and how sponsors can approach such issues. DCTs often present novel problems that sponsors conducting site-based clinical trials have not previously encountered.

FDA 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Episode 23: The Emerging Investigatory Focus on Telehealth: What You Need to Know

Healthcare Law Today

He advises entrepreneurial health care providers and technology companies on business arrangements, compliance, and corporate matters in telemedicine, digital health, remote patient monitoring, and click-and-mortar services. I’m currently Deputy General Counsel of LifeMD, a growing telemedicine company.

article thumbnail

Is Your Data Supply Chain Ethical? Don’t Restrict Due Diligence to Physical Operations.

C&M Health Law

This article was originally published in Corporate Compliance Insights. bribery, fraud, misuse). Health Insurance Portability and Accountability Act (HIPAA) can present several areas of exposure. Both your company’s data supply chain and its physical version have fundamentally similar business risks.

article thumbnail

AI in Healthcare

HIPAA Journal

AI is used by the finance industry to detect potential credit card fraud. Although specific concerns differ by organization, the concerns can generally be categorized as informed consent to use data, safety and transparency, algorithmic fairness, and data privacy. .

article thumbnail

The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023

Drug & Device Law

2023) ( Buckman preemption barred MDL asserting fraud on EPA), cert. Plaintiff knew about it, too, since he signed an informed consent document mentioning it. Negligence requires an evaluation of a defendant’s reasonableness, and all relevant NC authority includes relevant regulatory compliance in that mix. 4th 696 (3d.

FDA 105
article thumbnail

Suing the Certifiers – A Dangerous Undertaking

Drug & Device Law

Anyway, this fraudulent “doctor” allegedly “touched them without informed consent” and caused them “emotional distress. The unfortunate truth is that ECFMG was also a victim of this fake doctor’s fraud. has no power to enforce compliance”), aff’d , 405 F. 23 in its current form. Smith, LLC , 2010 WL 11566367, at *7 (N.D.

Doctors 52